Atlas Trials

FX-322 in Adults With Acquired Sensorineural Hearing Loss

Clinical trial NCT05086276 · COMPLETED

Trial details

NCT number
NCT05086276
Sponsor
Frequency Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hearing Loss, SensorineuralNoise Induced Hearing LossSudden Hearing Loss
Start date
2021-10-12
Primary completion
2022-12-30
Enrollment
142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.